Early predictive value of 18F-FDG-PET assessment in advanced esophagogastric junction and gastric cancer patients treated with cetuximab-containing therapy

被引:0
|
作者
Di Fabio, F.
Pinto, C.
Llimpe, F. Rojas
Castellucci, P.
Fanti, S.
Mutri, V.
Giaquinta, S.
Di Tullio, P.
Pini, S.
Compagnone, G.
Martoni, A.
机构
[1] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy
[2] St Orsola Marcello Malpighi Hosp, Nucl Med Unit, Bologna, Italy
[3] St Orsola Marcello Malpighi Hosp, Med Phys Unit, Bologna, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15601
引用
收藏
页数:2
相关论文
共 50 条
  • [31] 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer
    Driscoll, Dearbhail O.
    Halpenny, Darragh
    Johnston, Ciaran
    Sheehy, Niall
    Keogan, Mary
    ABDOMINAL IMAGING, 2015, 40 (01): : 127 - 133
  • [32] Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
    Liberini, Virginia
    Rubatto, Marco
    Mimmo, Riccardo
    Passera, Roberto
    Ceci, Francesco
    Fava, Paolo
    Tonella, Luca
    Polverari, Giulia
    Lesca, Adriana
    Bello, Marilena
    Arena, Vincenzo
    Ribero, Simone
    Quaglino, Pietro
    Deandreis, Desiree
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [33] Predictive value of baseline [18F]FDG PET/CT for response to systemic therapy in patients with advanced melanoma
    Liberini, V.
    Mimmo, R.
    Passera, R.
    Califaretti, E.
    Ceci, F.
    Fava, P.
    Rubatto, M.
    Tonella, L.
    Polverari, G.
    Ribero, S.
    Bello, M.
    Arena, V.
    Quaglino, P.
    Deandreis, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S378 - S378
  • [34] Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer
    Seok-Ki Kim
    Keon Wook Kang
    Jong Seok Lee
    Hark Kyun Kim
    Hee Jin Chang
    Jin Yi Choi
    Jun Ho Lee
    Keun Won Ryu
    Young-Woo Kim
    Jae-Moon Bae
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 148 - 155
  • [35] Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer
    Kim, SK
    Kang, KW
    Lee, JS
    Kim, HK
    Chang, HJ
    Choi, JY
    Lee, JH
    Ryu, KW
    Kim, YW
    Bae, JM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (02) : 148 - 155
  • [36] Metabolic activity by 18F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
    Kaira, Kyoichi
    Higuchi, Tetsuya
    Naruse, Ichiro
    Arisaka, Yukiko
    Tokue, Azusa
    Altan, Bolag
    Suda, Satoshi
    Mogi, Akira
    Shimizu, Kimihiro
    Sunaga, Noriaki
    Hisada, Takeshi
    Kitano, Shigehisa
    Obinata, Hideru
    Yokobori, Takehiko
    Mori, Keita
    Nishiyama, Masahiko
    Tsushima, Yoshihito
    Asao, Takayuki
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (01) : 56 - 66
  • [37] The predictive value of MRI and 18F-FDG-PET/CT for assessing pathological response in locally advanced rectal cancer after neoadjuvant chemoradiotherapy
    Avci, G. Guler
    Aral, I.
    LEUKEMIA RESEARCH, 2019, 85 : S35 - S35
  • [38] The predictive value of 18F-FDG-PET in the early detection of residual disease after larynx organ preserving chemoradiation
    Dietz, A
    Rudat, V
    Harms, W
    Jungehülsing, M
    Dollner, R
    Henze, M
    HNO, 2004, 52 (01) : 38 - 44
  • [39] 18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy
    Helsen, Nils
    Roothans, Dessie
    Van den Heuvel, Bert
    Van den Wyngaert, Tim
    Van den Weyngaert, Danielle
    Carp, Laurens
    Stroobants, Sigrid
    PLOS ONE, 2017, 12 (08):
  • [40] Prediction of treatment response to Lenvatinib with 18F-FDG-PET/CT in patients with advanced thyroid cancer
    Ahmaddy, F.
    Beyer, L.
    Wenter, V.
    Bartenstein, P.
    Todica, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S33 - S33